Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FD9E3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,864
Award facts
- Contract value 100% obligated
- $11,864.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. This firm fixed-price delivery order, valued at $11,864.09, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract utilized no set-aside designation and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical supply chain, supplying a broad portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's federal contracting activity demonstrates consistent capability in fulfilling competitively awarded pharmaceutical delivery orders with firm fixed pricing. Through its DLA partnership, AmerisourceBergen provides essential medical supplies to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a significant pharmaceutical prime vendor supporting global military healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FD9E3?
SPE2DB25FD9E3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FD9E3 worth?
The government has obligated $11,864 on SPE2DB25FD9E3.
Is contract SPE2DB25FD9E3 an order under another contract?
Yes. SPE2DB25FD9E3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD9E3 competed?
The extent of competition for SPE2DB25FD9E3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award